EGFR and glioblastoma: This framework underscores the molecular definition of GBM, where the presence of TERT promoter mutation, EGFR amplification, or combined whole chromosome +7/−10 copy number change is sufficient to establish the diagnosis, even in the absence of classical histopathological features [2].